While P2X1 receptor antagonists may be useful in thromboinflammatory diseases such as stroke, as they are known to drive platelet aggregation; more recently, P2X7 receptor antagonists were demonstrated to modulate platelet function as well. This evidence concerns the gene P2RX7 and Stroke.